A long-lasting gel-based diffuser of feline pheromone can help reduce undesirable behaviors in cats at home: comparison with an electric diffuser

Autor: Gemma Espuña, Céline S. Nicolas, Aurélie Girardin, Jaume Fatjó, Jonathan Bowen, Patricia Monginoux, Christophe A. Rème

Publikováno v: Frontiers in Veterinary Science, Vol 11 (2024)

Using pheromone diffusers is part of the strategy to control stress-related behaviors in cats (Felis catus). The goal of the study was to compare the efficacy of a novel long-acting, unpowered gel-based diffuser containing a facial pheromone analog (

Externí odkaz: https://doaj.org/article/7f5e02309d804a4295db296c4cb2103d

The use of recombinant omega interferon therapy in canine atopic dermatitis: a double-blind controlled study

Autor: Maxime Albouy, Pierre Jasmin, Didier N. Carlotti, Marc Boulet, Christophe A. Rème, Gustavo Machicote, Joël Ducret

Publikováno v: Veterinary Dermatology. 20:405-411

This double-blind controlled study assessed whether reduced doses of omega interferon (rFeIFN-omega) (Virbagen Omega) could improve the clinical signs of canine atopic dermatitis (CAD) over a 6-month period, in comparison with cyclosporin. Thirty-one

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e33b13ab74d4902b9f8c4a19267cc4c3
https://doi.org/10.1111/j.1365-3164.2009.00848.x

Efficacy of proactive long‐term maintenance therapy of canine atopic dermatitis with 0.0584% hydrocortisone aceponate spray: a double‐blind placebo controlled pilot study

Autor: Emi Maruhashi, Berta São Braz, Diana Nóbrega, Christophe A. Rème, Daniela Matias, Ana Mafalda Lourenço, José H. Duarte-correia, Vanessa Schmidt, Telmo Nunes, Tim Nuttall

Publikováno v: Lourenço, A M, Schmidt, V, São Braz, B, Nóbrega, D, Nunes, T, Duarte-correia, J H, Matias, D, Maruhashi, E, Rème, C A & Nuttall, T 2016, ' Efficacy of proactive long-term maintenance therapy of canine atopic dermatitis with 0.0584% hydrocortisone aceponate spray: a double-blind placebo controlled pilot study ', Veterinary Dermatology, vol. 27, no. 2, pp. 88-e25 . https://doi.org/10.1111/vde.12285

Background Long-term remission between flares of canine atopic dermatitis (CAD) can be difficult to achieve. Therefore, additional strategic forms of treatment are needed in order to target flare prevention. The concept of proactive therapy is recomm

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::332300cf29b9f57e86153d79cc8ca0a6
https://doi.org/10.1111/vde.12285

Comparable efficacy of a topical 0.0584% hydrocortisone aceponate spray and oral ciclosporin in treating canine atopic dermatitis

Autor: Tim J, Nuttall, Neil A, McEwan, Emmanuel, Bensignor, Luisa, Cornegliani, Christine, Löwenstein, Christophe A, Rème

Publikováno v: Veterinary dermatology. 23(1)

This study compared the efficacy of a 0.0584% hydrocortisone aceponate (HCA) spray (Cortavance(®); Virbac SA) and ciclosporin (Atopica(®); Novartis Animal Health) in canine atopic dermatitis in a single-blind randomized controlled trial. Dogs recei

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::48723acb3c17027f5bc017cb8793e6f8
https://pubmed.ncbi.nlm.nih.gov/21718368

The use of recombinant omega interferon therapy in canine atopic dermatitis: a double-blind controlled study

Autor: Didier Noël, Carlotti, Marc, Boulet, Joël, Ducret, Gustavo, Machicote, Pierre, Jasmin, Christophe A, Rème, Maxime, Albouy

Publikováno v: Veterinary dermatology. 20(5-6)

This double-blind controlled study assessed whether reduced doses of omega interferon (rFeIFN-omega) (Virbagen Omega) could improve the clinical signs of canine atopic dermatitis (CAD) over a 6-month period, in comparison with cyclosporin. Thirty-one

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e41e6b7c5d69043b878eda7c9a4044c2
https://pubmed.ncbi.nlm.nih.gov/20178477